Candidate Compounds Covid19

Aus coViki
Wechseln zu: Navigation, Suche

coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.

current items will be put into the subsections.






  • GET 2020. Blocking angiotensin earlier with RAS blockers, statins, and heparin in high-risk COVID-19 patients: Is the remedy here? Extract
  • GET 2020. How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19. Extract
  • GET 2020. Could Ergothioneine Aid in the Treatment of Coronavirus Patients? Extract
  • GET 2020. Controle do Intervalo QT para Prevencao de Torsades de Pointes Durante uso de Hidroxicloroquina e/ou Azitromicina em Pacientes com COVID 19. Extract
  • GET 2020. Ten-Year Research Update Review: Antiviral Activities from Marine Organisms. Extract
  • GET 2020. Need for Speed: From Human SARS-CoV-2 Samples to Protective and Efficacious Antibodies in Weeks. Extract
  • GET 2020. Is hydroxychloroquine beneficial for COVID-19 patients? Extract
  • GET 2020. Double-edged sword: Granulocyte colony stimulating factors in cancer patients during the COVID-19 era. Extract
  • GET 2020. Challenges in evaluating SARS-CoV-2 vaccines during the COVID-19 pandemic. Extract
  • GET 2020. Effect of favipiravir and an anti-inflammatory strategy for COVID-19. Extract
  • GET 2020. Clarifying the controversial risk-benefit profile of soluble ACE2 in COVID-19. Extract
  • GET 2020. Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series. Extract
  • GET 2020. A Centrally Acting Antihypertensive, Clonidine, Sedates Patients Presenting With Acute Respiratory Distress Syndrome Evoked by Severe Acute Respiratory Syndrome-Coronavirus 2. Extract
  • GET 2020. Vitamin D deficiency in patients with diabetes and COVID- 19 infection. Extract
  • GET 2020. Application of Artificial Intelligence in COVID-19 drug repurposing. Extract
  • GET 2020. Concentration-dependent mortality of chloroquine in overdose. Extract
  • GET 2020. Shotgun proteomics analysis of SARS-CoV-2-infected cells and how it can optimize whole viral particle antigen production for vaccines. Extract
  • GET 2020. Profiles of COVID-19 clinical trials in the Chinese Clinical Trial Registry. Extract
  • GET 2020. Potential of regulatory T cell-based therapies in the management of severe COVID-19. Extract
  • GET 2020. Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease. Extract
  • GET 2020. Use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in context of COVID-19 outbreak: a retrospective analysis. Extract
  • GET 2020. Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2. Extract
  • GET 2020. Prophylactic (hydroxy)chloroquine in COVID-19: potential relevance for cardiac arrhythmia risk. Extract
  • GET 2020. INCIDENCE OF ARRHYTHMIAS AND ELECTROCARDIOGRAPHIC ABNORMALITIES IN SYMPTOMATIC PEDIATRIC PATIENTS WITH PCR POSITIVE SARS-CoV-2 INFECTION INCLUDING DRUG INDUCED CHANGES IN THE CORRECTED QT INTERVAL (QTc). Extract
  • GET 2020. Curcumin: a Wonder Drug as a Preventive Measure for COVID19 Management. Extract
  • GET 2020. Hydroxychloroquine and Covid-19: A Cellular and Molecular Biology Based Update. Extract
  • GET 2020. Povidone-Iodine Demonstrates Rapid In Vitro Virucidal Activity Against SARS-CoV-2, The Virus Causing COVID-19 Disease. Extract
  • GET 2020. Identification of potential inhibitors against SARS-CoV-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches. Extract
  • GET 2020. Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab. Extract
  • GET 2020. An update on antiviral antibody-based biopharmaceuticals. Extract
  • GET 2020. Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19. Extract
  • GET 2020. COVID-19 Treatment: Close to a Cure? - A Rapid Review of Pharmacotherapies for the Novel Coronavirus. Extract
  • GET 2020. Clinical characteristics and predictors of survival in adults with coronavirus disease 2019 receiving tocilizumab. Extract
  • GET 2020. CNS Penetration Ability: A Critical Factor for Drugs in the Treatment of SARS-CoV-2 Brain Infection. Extract
  • GET 2020. Passive immunization: Paradoxical and traditional method for new pandemic challenge COVID-19. Extract
  • GET 2020. COVID-19 and Mesenchymal Stem Cell Treatment; Mystery or Not. Extract
  • GET 2020. Very Long-acting Antivirals as Chemovaccines for Preventing Viral Infections. Extract
  • GET 2020. Poly(ADP-ribose) Polymerase Inhibition in Acute Lung Injury: A Re-emerging Concept. Extract
  • GET 2020. COVID-19 Clinical Trials: Unravelling a Methodological Gordian Knot. Extract
  • GET 2020. Regulatory T Cells for Treating Patients With COVID-19 and Acute Respiratory Distress Syndrome: Two Case Reports. Extract
  • GET 2020. Interleukin-6 receptor blockade with subcutaneous tocilizumab in severe COVID-19 pneumonia and hyperinflammation: a case-control study. Extract
  • GET 2020. Serological tests confirm the low incidence of COVID-19 in chronic rheumatic inflammatory diseases treated with biological DMARD. Extract
  • GET 2020. COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study. Extract
  • GET 2020. Response to: 'COVID-19 in paediatric rheumatology patients treated with b/tsDMARDs: a cross-sectional patient survey study' by Cuceoglu et al. Extract
  • GET 2020. Interleukin-6 blockade with sarilumab in severe COVID-19 pneumonia with systemic hyperinflammation: an open-label cohort study. Extract
  • GET 2020. Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma Concentrations. Extract
  • GET 2020. Clinical trials of repurposed antivirals for SARS-CoV-2. Extract
  • GET 2020. Trainee Led Collaboratives, Clinical Trials And New Opportunities In The Covid-19 Era. Extract
  • GET 2020. Nutrients in prevention, treatment, and management of viral infections; special focus on Coronavirus. Extract
  • GET 2020. Vaccines, convalescent plasma, and monoclonal antibodies for covid-19. Extract
  • GET 2020. Urgent call for greater multilateralism and coordination of covid-19 trials. Extract
  • GET 2020. Covid-19: research methods must be flexible in a crisis. Extract
  • GET 2020. Dexamethasone in the management of covid -19. Extract
  • GET 2020. Covid-19: Lopinavir-ritonavir does not benefit hospitalised patients, UK trial finds. Extract
  • GET 2020. COVID-19 clinical trials: see it big and keep it simple. Extract
  • GET 2020. Serious adverse events with tocilizumab: pharmacovigilance as an aid to prioritize monitoring in COVID-19. Extract
  • GET 2020. Potential role of IL-17 blocking agents in the treatment of severe COVID-19? Extract
  • GET 2020. Double-bright (CD56bright/CD16bright) NK cell adoptive immunotherapy for SARS-CoV-2. Extract
  • GET 2020. COVID-19 pandemic and management of GIMEMA clinical trials: changes and challenges. Extract
  • GET 2020. Proteinase-activated receptor 1 (PAR1): A target for repurposing in the treatment of COVID-19? Extract
  • GET 2020. Current Therapies Under Investigation for COVID-19. Extract
  • GET 2020. Interaction of hydroxychloroquine with SARS-CoV2 functional proteins using all-atoms non-equilibrium alchemical simulations. Extract
  • GET 2020. Construction and immunogenic studies of a mFc fusion receptor binding domain (RBD) of spike protein as a subunit vaccine against SARS-CoV-2 infection. Extract
  • GET 2020. Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity. Extract
  • GET 2020. Immune checkpoint inhibition in the era of COVID-19. Extract
  • GET 2020. Proposing minimum requirements for announcing clinical trial results during the COVID-19 pandemic. Extract
  • GET 2020. Evaluating use cases for human challenge trials in accelerating SARS-CoV-2 vaccine development. Extract
  • GET 2020. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Extract
  • GET 2020. Smoking in critically ill patients with COVID-19: the Australian experience. Extract
  • GET 2020. Analytical Methods on Determination in Pharmaceuticals and Biological Materials of Chloroquine as Available for the Treatment of COVID-19. Extract
  • GET 2020. Effect of the Phytochemical Agents Against the SARS-CoV and Selected Some of them for Application to COVID-19: A Mini-Review. Extract
  • GET 2020. Repurposing Drugs for the Management of Patients with Confirmed Coronavirus Disease 2019 (COVID-19). Extract
  • GET 2020. The role of Chloroquine and Hydroxychloroquine in Immune Regulation and Diseases. Extract
  • GET 2020. Elucidating the Pivotal Role of Immune Players in the Management of COVID-19: Focus on Mesenchymal Stem Cells and Inflammation. Extract
  • GET 2020. Therapeutic targets and computational approaches on drug development for COVID-19. Extract
  • GET 2020. Shape-based Machine Learning Models for the potential Novel COVID-19 protease inhibitors assisted by Molecular Dynamics Simulation. Extract
  • GET 2020. Network pharmacology and molecular docking analysis on molecular targets and mechanisms of Huashi Baidu formula in the treatment of COVID-19. Extract
  • GET 2020. Revisiting potential druggable targets against SARS-CoV-2 and repurposing therapeutics under preclinical study and clinical trials: A comprehensive review. Extract
  • GET 2020. Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges. Extract
  • GET 2020. BET 2: Hydroxychloroquine in the treatment of COVID-19. Extract
  • GET 2020. BET 1: Lopinavir-ritonavir and COVID-19. Extract
  • GET 2020. Bacillus Calmette-Guerin vaccination and clinical characteristics and outcomes of COVID-19 in Rhode Island, United States: a cohort study. Extract
  • GET 2020. SGLT2 inhibition and COVID-19: The road not taken. Extract
  • GET 2020. Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process? Extract
  • GET 2020. Repurposing of well-known medications as antivirals: hydroxychloroquine and chloroquine - from HIV-1 infection to COVID-19. Extract
  • GET 2020. Predictor of poor prognosis of COVID-19 patients----liver injury. Extract
  • GET 2020. Liver injury in severe COVID-19 infection: current insights and challenges. Extract
  • GET 2020. Balancing infection control and frailty prevention during and after the COVID-19 pandemic: Introduction of the NCGG Home Exercise Program for Older People 2020. Extract
  • GET 2020. Isopathic Remedy Prepared from Convalescent Plasma as a Therapeutic Option for COVID-19? Extract
  • GET 2020. Thinking more about therapy with convalescent plasma for COVID-19 patients. Extract
  • GET 2020. Successful Treatment of Covid-19 Associated Cytokine Release Syndrome with Colchicine. A Case Report and Review of Literature. Extract
  • GET 2020. Effect of recombinant human granulocyte colony-stimulating factor on lymphocyte subsets in patients with COVID-19. Extract
  • GET 2020. Suggestions for Combatting COVID-19 by Natural Means in the Absence of Standard Medical Regimens. Extract
  • GET 2020. Combating COVID-19 and Building Immune Resilience: A Potential Role for Magnesium Nutrition? Extract
  • GET 2020. Identification of bioactive molecule from Withania somnifera (Ashwagandha) as SARS-CoV-2 main protease inhibitor. Extract
  • GET 2020. Potential of NO donor furoxan as SARS-CoV-2 main protease (M(pro)) inhibitors: in silico analysis. Extract
  • GET 2020. Natural-like products as potential SARS-CoV-2 M(pro) inhibitors: in-silico drug discovery. Extract
  • GET 2020. Screening of phytochemical compounds of Tinospora cordifolia for their inhibitory activity on SARS-CoV-2: an in silico study. Extract
  • GET 2020. Possibility of HIV-1 protease inhibitors-clinical trial drugs as repurposed drugs for SARS-CoV-2 main protease: a molecular docking, molecular dynamics and binding free energy simulation study. Extract
  • GET 2020. Bacterial protein azurin and derived peptides as potential anti-SARS-CoV-2 agents: insights from molecular docking and molecular dynamics simulations. Extract
  • GET 2020. Epitope based peptide vaccine against SARS-COV2: an immune-informatics approach. Extract
  • GET 2020. Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights. Extract
  • GET 2020. Excavating SARS-coronavirus 2 genome for epitope-based subunit vaccine synthesis using immunoinformatics approach. Extract
  • GET 2020. Convalescent plasma therapy in patients with COVID-19. Extract
  • GET 2020. Hydroxychloroquine and COVID-19: critiquing the impact of disease public profile on policy and clinical decision-making. Extract
  • GET 2020. Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management. Extract
  • GET 2020. Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection. Extract
  • GET 2020. Erythropoietin Induced Hemoglobin Sub-Unit Beta may Stimulate Innate Immune RNA Virus Pattern Recognition, Suppress Reactive Oxygen Species, Reduce ACE2 Viral Doorway Opening and Neutrophil Extracellular Traps against Covid-19. Extract
  • GET 2020. A retrospective review of memantine use and COVID-19-associated mortality from a national database. Extract
  • GET 2020. RNA-dependent RNA Polymerase of SARS-CoV-2 as a Therapeutic Target. Extract
  • GET 2020. Lopinavir/ritonavir is associated with pneumonia resolution in COVID-19 patients with influenza coinfection: a retrospective matched-pair cohort study. Extract
  • GET 2020. Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis. Extract
  • GET 2020. Corticosteroid therapy for patients with CoVID-19 pneumonia: a before-after study. Extract
  • GET 2020. A pharmacological perspective of Chloroquine in SARS-CoV-2 infection. Extract
  • GET 2020. Case reports study of the first five patients COVID-19 treated with remdesivir in France. Extract
  • GET 2020. Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy. Extract
  • GET 2020. Treatment with Hydroxychloroquine, Azithromycin, and Combination in Patients Hospitalized with COVID-19. Extract
  • GET 2020. An Observational Cohort Study of Hydroxychloroquine and Azithromycin for COVID-19: (Can't Get No) Satisfaction. Extract
  • GET 2020. Influence of Herbal Medicines on HMGB1 Release, SARS-CoV-2 Viral Attachment, Acute Respiratory Failure, and Sepsis. A Literature Review. Extract
  • GET 2020. Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products. Extract
  • GET 2020. Clinical guidance for navigating the QTc-prolonging and arrhythmogenic potential of pharmacotherapy during the COVID-19 pandemic. Extract
  • GET 2020. Nucleic Acid Approaches to Antibody-based Therapeutics for COVID-19: A Perspective. Extract
  • GET 2020. SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy. Extract
  • GET 2020. Role of Lopinavir/Ritonavir in the Treatment of Covid-19: A Review of Current Evidence, Guideline Recommendations, and Perspectives. Extract
  • GET 2020. SARS-CoV-2: Repurposed Drugs and Novel Therapeutic Approaches-Insights into Chemical Structure-Biological Activity and Toxicological Screening. Extract
  • GET 2020. Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia? (). Extract
  • GET 2020. Azithromycin and SARS-CoV-2 infection: where we are now and where we are going. Extract
  • GET 2020. BCG vaccine and COVID-19: implications for infection prophylaxis and cancer immunotherapy. Extract
  • GET 2020. On the use of immune checkpoint inhibitors in patients with viral infections including COVID-19. Extract
  • GET 2020. Convalescent Plasma Therapy in Coronavirus Disease 2019: a Case Report and Suggestions to Overcome Obstacles. Extract
  • GET 2020. Mild COVID-19 infection in an NMO patient treated with tocilizumab: a confirmation of anti-IL-6 protective role? Extract
  • GET 2020. Evolving geographic diversity in SARS-CoV2 and in silico analysis of replicating enzyme 3CL(pro) targeting repurposed drug candidates. Extract
  • GET 2020. Analysis of SARS-CoV-2 RNA-dependent RNA polymerase as a potential therapeutic drug target using a computational approach. Extract
  • GET 2020. Systematic review of the registered clinical trials for coronavirus disease 2019 (COVID-19). Extract
  • GET 2020. Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19. Extract
  • GET 2020. Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy. Extract
  • GET 2020. Microbial Natural Products as Potential Inhibitors of SARS-CoV-2 Main Protease (M(pro)). Extract
  • GET 2020. Aptamers, the bivalent agents as probes and therapies for coronavirus infections: A systematic review. Extract
  • GET 2020. Caspase1/11 signaling affects muscle regeneration and recovery following ischemia, and can be modulated by chloroquine. Extract
  • GET 2020. Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice. Extract
  • GET 2020. The risk of QTc-interval prolongation in COVID-19 patients treated with chloroquine. Extract
  • GET 2020. COVID-19 and vitamin D deficiency, a fatal combination? Extract
  • GET 2020. SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings. Extract
  • GET 2020. Edaravone: A potential treatment for the COVID-19-induced inflammatory syndrome? Extract
  • GET 2020. Chinese herbal medicine for coronavirus disease 2019: A systematic review and meta-analysis. Extract
  • GET 2020. Ultraviolet-based Biophotonic Technologies and COVID-19. Extract
  • GET 2020. Discovery of potent thrombin inhibitors from a protease-focused DNA-encoded chemical library. Extract
  • GET 2020. Letter to the editor regarding "Lack of supporting data make the risks of a clinical trial of radiation therapy as a treatment for COVID-19 pneumonia unacceptable". Extract
  • GET 2020. Primum non nocere - Are chloroquine and hydroxychloroquine safe prophylactic/treatment options for SARS-CoV-2 (covid-19)? Extract
  • GET 2020. A candidate multi-epitope vaccine against SARS-CoV-2. Extract
  • GET 2020. Alternative management of Covid-19 infection. Extract
  • GET 2020. First case of convalescent plasma transfusion in a child with COVID-19-associated severe aplastic anemia. Extract
  • GET 2020. Hydroxychloroquine safety: A meta-analysis of randomized controlled trials. Extract
  • GET 2020. No evidence of clinical benefits of early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: Comment on "Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France". Extract
  • GET 2020. Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation During Acute Respiratory Distress: A Case Report and Literature Review. Extract
  • GET 2020. Prospects and Challenges in the Development of Universal Influenza Vaccines. Extract
  • GET 2020. Immunoinformatic Analysis of T- and B-Cell Epitopes for SARS-CoV-2 Vaccine Design. Extract
  • GET 2020. Epitope-based peptide vaccines predicted against novel coronavirus disease caused by SARS-CoV-2. Extract
  • GET 2020. Repurposing Therapeutics for Potential Treatment of SARS-CoV-2: A Review. Extract
  • GET 2020. Low Dose Radiation to COVID-19 Patients to Ease the Disease Course and Reduce the Need of Intensive Care. Extract
  • GET 2020. Are we aware of potential interactions between drugs used in lung cancer and drugs used in the treatment of COVID-19? Extract
  • GET 2020. The Development of COVID-19 Vaccines: Safeguards Needed. Extract
  • GET 2020. Developing a SARS-CoV-2 Vaccine at Warp Speed. Extract
  • GET 2020. Evolution of Altered Sense of Smell or Taste in Patients With Mildly Symptomatic COVID-19. Extract
  • GET 2020. Editorial - Nutritional Status Affects COVID-19 Patient Outcomes. Extract
  • GET 2020. Evaluation of Nutritional Risk and its Association With Mortality Risk in Severe and Critically Ill COVID-19 Patients. Extract
  • GET 2020. Low dose radiation as a treatment for COVID-19 pneumonia: a threat or real opportunity? Extract
  • GET 2020. Virtual screening based on molecular docking of possible inhibitors of Covid-19 main protease. Extract
  • GET 2020. Safety of Plasma Infusions in Parkinson's Disease. Extract
  • GET 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply. Extract
  • GET 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Extract
  • GET 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Extract
  • GET 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Extract
  • GET 2020. Remdesivir for the Treatment of Covid-19 - Preliminary Report. Extract
  • GET 2020. Bioactive compounds from marine resources against novel corona virus (2019-nCoV): in silico study for corona viral drug. Extract
  • GET 2020. COVID-19 platform trial delivers. Extract
  • GET 2020. Going back in time for an antibody to fight COVID-19. Extract
  • GET 2020. Golden Anniversary of the Nicotinic Receptor. Extract
  • GET 2020. Tocilizumab and Remdesivir in a Pregnant Patient With Coronavirus Disease 2019 (COVID-19). Extract
  • GET 2020. Is povidone-iodine mouthwash effective against SARS-CoV-2? First in vivo tests. Extract
  • GET 2020. Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19. Extract
  • GET 2020. COVID-19: Phylogenetic approaches may help in finding resources for natural cure. Extract
  • GET 2020. BCG vaccine protection from severe coronavirus disease 2019 (COVID-19). Extract
  • GET 2020. Immunopathology and immunotherapeutic strategies in severe acute respiratory syndrome coronavirus 2 infection. Extract
  • GET 2020. Using heat to kill SARS-CoV-2. Extract
  • GET 2020. Can interferons stop COVID-19 before it takes hold? Extract
  • GET 2020. Potential Immunotherapeutic Targets For Hypoxia Due to COVI-FLU. Extract
  • GET 2020. COVID-19 drug repurposing: Summary statistics on current clinical trials and promising untested candidates. Extract
  • GET 2020. Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation. Extract
  • GET 2020. SARS-CoV2 and immunosuppression: a double-edged sword. Extract
  • GET 2020. Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib. Extract
  • GET 2020. Review of the SARS-CoV-2 in Wuhan and Analysis as Well as Prediction of Therapeutic Drugs. Extract
  • GET 2020. Designing of improved drugs for COVID-19: Crystal structure of SARS-CoV-2 main protease M(pro). Extract
  • GET 2020. The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin. Extract
  • GET 2020. Angiotensin converting enzyme: A review on expression profile and its association with human disorders with special focus on SARS-CoV-2 infection. Extract
  • GET 2020. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein. Extract
  • GET 2020. Gut microbiota and Covid-19- possible link and implications. Extract
  • GET 2020. On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2. Extract
  • GET 2020. Individual variation of the SARS-CoV-2 receptor ACE2 gene expression and regulation. Extract
  • GET 2020. Neutralization of SARS-CoV-2 by Destruction of the Prefusion Spike. Extract
  • GET 2020. Micronutrient status of COVID-19 patients: a critical consideration. Extract
  • GET 2020. Rationale for targeting Complement in COVID-19. Extract
  • GET 2020. Evolutionary relationships and sequence-structure determinants in human SARS coronavirus-2 spike proteins for host receptor recognition. Extract
  • GET 2020. A role for selenium-dependent GPX1 in SARS-CoV-2 virulence. Extract
  • GET 2020. Pulmonary surfactant itself must be a strong defender against SARS-CoV-2. Extract
  • GET 2020. Statins and other drugs: Facing COVID-19 as a vascular disease. Extract
  • GET 2020. COVID-19, acute respiratory distress syndrome (ARDS), and hyperbaric oxygen therapy (HBOT): what is the link? Extract
  • GET 2020. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge. Extract
  • GET 2020. The Role of MicroRNA in the Airway Surface Liquid Homeostasis. Extract
  • GET 2020. Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight? Extract
  • GET 2020. The cholinergic anti-inflammatory pathway alleviates acute lung injury. Extract
  • GET 2020. Airways Expression of SARS-CoV-2 Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD. Extract
  • GET 2020. Gut-lung axis and dysbiosis in COVID-19. Extract
  • GET 2020. Door to the cell for COVID-19 opened, leading way to therapies. Extract
  • GET 2020. Use of Anakinra to Prevent Mechanical Ventilation in Severe COVID-19: A Case Series. Extract
  • GET 2020. Targeting the entry step of SARS-CoV-2: a promising therapeutic approach. Extract
  • GET 2020. Early Hemoperfusion for Cytokine Removal May Contribute to Prevention of Intubation in Patients Infected with COVID-19. Extract
  • GET 2020. ACE2, Much More Than Just a Receptor for SARS-COV-2. Extract
  • GET 2020. Relative Abundance of SARS-CoV-2 Entry Genes in the Enterocytes of the Lower Gastrointestinal Tract. Extract
GET 2020. Why is SARS-CoV-2 infection more severe in obese men? The gut lymphatics - Lung axis hypothesis. Extract
  • GET 2020. Elucidation of Cellular Targets and Exploitation of the Receptor Binding Domain of SARS-CoV-2 for vaccine and monoclonal antibody synthesis. Extract
  • GET 2020. Critical Differences Between the Binding Features of the Spike Proteins of SARS-CoV-2 and SARS-CoV. Extract
  • GET 2020. The Discovery of a Putative Allosteric Site in the SARS-CoV-2 Spike Protein Using an Integrated Structural/Dynamic Approach. Extract
  • GET 2020. Identification of common deletions in the spike protein of SARS-CoV-2. Extract
  • GET 2020. Genomic discovery of an evolutionarily programmed modality for small-molecule targeting of an intractable protein surface. Extract
  • GET 2020. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection. Extract
  • GET 2020. Supplements for COVID-19: A modifiable environmental risk. Extract
Meine Werkzeuge
Namensräume
Varianten
Aktionen
Navigation
Werkzeuge